StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
XTXX

Adastra Holdings Ltd.

XTXXF Pharmaceutical Preparations EDGAR ↗
$0.01
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$392K
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
—
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
—
Total assets ⓘ
—
Gross margin ⓘ
—
52-week range ⓘ
$0.01 – $0.51

AI briefing

from the latest 10-K, 10-Q and 8-K events

Adastra Holdings Ltd. is a Canadian pharmaceutical preparations company that filed its annual report on Form 20-F for fiscal year 2022.

What they do

The filing excerpts do not describe the company's actual operations, products, or services. The document contains only structured financial data tags and references to intangible assets such as brand names and patient relationships. No business description is available in the excerpted text.

Revenue drivers

  • Not disclosed in excerpts — The filing excerpts contain no segment revenue data or product-level revenue breakdowns.
  • Not disclosed in excerpts — Customer concentration references (Customer One, Customer Two, Customer Three, Four Customers, Two Customers) appear as tags but no amounts are provided.
  • Not disclosed in excerpts — Intangible asset classes include brand names and patient relationships, but no revenue attribution is shown.

Recent performance

The excerpts provide no income statement figures, revenue amounts, or net income/loss data. References to amortization of brand names and patient relationships for 2020, 2021, and 2022 exist but without values. No performance narrative is available from the source material.

Strategy

No strategy discussion is present in the excerpted text. The filing contains tags related to private placements, convertible debentures, mortgages, and compensation options, but no management commentary on direction or priorities. No investments or stated priorities are described in the provided source material.

Risks

  • Insufficient disclosure — The filing excerpts provide no business description, making it impossible to assess operational risks specific to Adastra Holdings Ltd.
  • Customer concentration — Tags reference Customer One, Customer Two, Customer Three, and groups of two and four customers, but the excerpts do not quantify the extent of concentration.
  • Intangible asset amortization — Brand names and patient relationships are subject to amortization, but the excerpts do not disclose amounts or impairment testing results.
  • Debt structure — Multiple mortgage tags (second through fifth) appear in the filing, indicating secured borrowings, but terms and amounts are not shown in the excerpts.

Outlook

No forward-looking statements or management outlook are present in the excerpted filing text. The source material contains only structured data tags without narrative guidance. No outlook can be provided based solely on the provided excerpts.